約372,000,000件1ページ目

日本語のみで絞り込む

an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

The Moderna COVID-19 Vaccine (2024-2025 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19.

Our mission is to deliver the greatest possible impact to people through mRNA medicines. Biotechnology Company Cambridge, MA modernatx.com Joined December 2013

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made.

Moderna Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA).

モデルナ

モデルナ(Moderna [məˈdɜːrnə])は、アメリカ合衆国マサチューセッツ州ケンブリッジに本社を置くバイオテクノロジー企業。メッセ...Wikipedia

  • 株価32.06ドル前日比+0.48ドル(+1.52%)
    7月16日20時00分(現地時間) 現在ご注意
  • 時価総額12,398,943千ドル
  • 代表者Stéphane Bancel
  • 本部所在地ケンブリッジ
  • 設立2016年7月22日
  • ケンブリッジ